Gordian knot: Medication overuse headache;Der gordische knoten: Medikamenteninduzierte kopfschmerzen

Schmerz

Volumn 18, Issue 5, 2004, Pages 421-423

  Katsarava, Z ^a   Fritsche, G ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Medication overuse; Medication overuse headache; Migraine; Relapse rate; Tension type headache

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; CAFFEINE; CODEINE; ERGOT DERIVATIVE; OPIATE DERIVATIVE;

CLINICAL FEATURE; DRUG WITHDRAWAL; HEADACHE; HUMAN; MIGRAINE; PROPHYLAXIS; RELAPSE; REVIEW; SIDE EFFECT; TENSION HEADACHE;

ANALGESICS; CAFFEINE; CODEINE; DRUG THERAPY, COMBINATION; HEADACHE; HUMANS; NARCOTICS;

EID: 5644280145     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-004-0355-x     Document Type: Review

References (30)

1. Bahra A, Walsh M, Menon S, Goadsby PJ (2000) Does chronic daily headache arise de novo in association with regular analgesic use? Cephalalgia 20:294 [abstr]
2. Baumgartner C, Wessely P, Bingol C, Maly J, Holzner F (1989) Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 29 510-514
3. Castillo J, Munoz P, Guitera V, Pascual J (1999) Epidemiology of chronic daily headache in the general population. Headache 39.190-196
4. Dichgans J, Diener HC, Gerber WD, Verspohl EJ, Kukiolka H, Kluck M (1984) Analgetika-induzierter Dauerkopfschmerz Dtsch Med Wochenschr 109:369-373
5. Diener HC, Dahlof CGH (1999) Headache associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The headaches, 2nd edn. Lippincott, Williams & Wilkins, Philadelphia, pp 871-878
6. Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A (1989) Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 236:9-14
7. Diener HC, Haab J, Peters C, Ried S, Dichgans J, Pilgrim A (1990) Subcutaneous sumatriptan in the treatment of headache during withdrawal from MOH Headache 31:205-209
8. Evers S, Bauer B, Suhr B, Wieser T, Husstedt I (1997) The epidemiology of sumatriptan abuse In. Olesen J, Tfelt-Hansen P (eds) Headache treatment trial methodology and new drugs. Lippincott-Raven, Philadelphia, pp 149-152
9. Fisher MA, Glass S (1997) Butorphanol (stadol): a study in problems of current drug information and control. Neurology 48.1156-1160
10. Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC (2001) Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse Eur Neurol 45:229-235
11. Gaist D (1999) Use and overuse of sumatriptan Pharmacoepidemiological studies based on prescription register and interview data. Cephalalgia 19:735-761
12. Gobel H, Stolze H, Heinze A, Dworschak M (1996) Easy therapeutical management of sumatriptan-induced daily headache. Neurology 47:297-298
13. Granella F, Farina S, Malferrari G, Manzoni GC (1987) Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia 7.15-19
14. Headache Classification Committee of the International Headache Society (2004) International Classification of Headache Disorders-II. Cephalalgia 24 [suppl 1]
15. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V (2001) Clinical features of withdrawal headache following overuse of triptans and other headache drugs Neurology 57:1694-1698
16. Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G (2003) Rates and predictors for relapse in medication overuse headache, a 1-year prospective study. Neurology 60:1682-1683
17. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62:788-790
18. Krymchantowski AV, Barbosa JS (2000) Prednisone as initial treatment of analgesic-induced daily headache Cephalalgia 20:107-113
19. Limmroth V, Kazarawa S, Fritsche G, Diener HC (1999) Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan. Lancet 353:378
20. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC (2002) Features of medication overuse headache following overuse of different acute headache drugs Neurology 59.1011-1014
21. Linton-Dahlof P, Linde M, Dahlof C (2000) Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 20.658-662
22. Mathew NT (1987) Amelioration of ergotamine withdrawal with naproxen. Headache 27:130-133
23. Pini LA, Bigarelli M, Vitale G, Sternieri E (1996) Headaches associated with chronic use of analgesics: a therapeutic approach Headache 36:433-439
24. Rapoport A, Stang P, Gutterman DL, Cady R, Markley H, Weeks R, Saiers J, Fox AW (1996) Analgesic rebound headache in clinical practice: data from a physician survey. Headache 36:14-19
25. Schnider P, Aull S, Baumgartner C, Marterer A, Wober C, Zeiler K, Wessely P (1996) Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five year follow-up. Cephalalgia 16:481-485
26. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW (1999) Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 19:44-49
27. Tfelt-Hansen P, Krabbe AA (1981) Ergotamine abuse: Do patients benefit from withdrawal? Cephalalgia 1:29-31
28. Tribl G, Schnider P, Wober C, Aull S, Auterith A, Zeiler K, Wessely P (2001) Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia 21:691-696
29. Wang SJ, Fuh JL, Lu SR, Liu CY, Hsu LC, Wang PN, Liu HC (2000) Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 54:314-319
30. Ziegler DK (1994) Opiate und opioid use in patients with refractory headache Cephalalgia 14:5-10